Marble Arch Research, Inc. Initiates Research Coverage of Healixa Inc.
The sponsored research also carries a rating and a price target and can be accessed at https://emerginggrowth.com/marble-arch-research-report-healixa-inc-otc-p...\nIn the update report released today, Marble Arch Research notes that, \xe2\x80\x9cUsing a comps-based valuation approach, we believe EMOR should be trading at $2.8-$3.3 per share vs the prevailing $1.20.
- The sponsored research also carries a rating and a price target and can be accessed at https://emerginggrowth.com/marble-arch-research-report-healixa-inc-otc-p...\nIn the update report released today, Marble Arch Research notes that, \xe2\x80\x9cUsing a comps-based valuation approach, we believe EMOR should be trading at $2.8-$3.3 per share vs the prevailing $1.20.
- For example, forward-looking statements are used when discussing our expected research and development programs, and more.
- Except as otherwise required by law, Healixa Inc., f.k.a.
- Emerald Organic Products, Inc., undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.\n'